![](https://investorshub.advfn.com/uicon/158678.png?cb=1661594561)
Saturday, September 13, 2014 9:15:01 PM
I looked at the USPTO.gov site to see if they had registered the trademark or applied for some kind of patent and found nothing....the only live trademark that the company has registered is the wordmark "Nanoviricides" and you know the patent story better than I do. The little TM that they use may protect the ADIF™ and Accurate-Drug-In-Field™ names through usage, but that hardly qualifies as IP worth owning. There could be an unpublished patent application, but there's no way to know that and there's no use of the term "proprietary" related to the process on the NNVC website.
It's a fine idea, but I don't know that it's patentable. Any concerns about a licensing conflict or arrangement with any related party seems unnecessary if it's not.
On a distantly related note, Diwan's latest filing showed an interesting change. His common holdings, which had been held directly by him in his name, suddenly appeared as Indirect holdings being held by Allexcel. If he sold or otherwise transferred his personal holdings to that company for some reason, as the filing implies, he should have provided an interim filing showing that transaction and there's no sign of one. It needs clearing up.
http://www.sec.gov/Archives/edgar/data/1379006/000114036114035027/xslF345X03/doc1.xml
The prior filing:
http://www.sec.gov/Archives/edgar/data/1379006/000114036114009355/xslF345X03/doc1.xml
"I ated the purple berries"
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM